Park Place Capital Corp »

Eyepoint Pharmaceuticals shares owned by Park Place Capital Corp

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Park Place Capital Corp from 13F filings

Historical chart of Park Place Capital Corp investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Park Place Capital Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Park Place Capital Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $475 23 20.65

More positions owned by Park Place Capital Corp

Ishares Core S&p 500 Etf Etf (IVV)
Microsoft Corp Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Ishares S&p 500 Growth Etf Etf (IVW)
Aptus Defined Risk Etf Etf (DRSK)
Ishares S&p 500 Value Etf Etf (IVE)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Aptus Collared Investment Opportunity Etf Etf (ACIO)
Apple Stock (AAPL)
Ishares Mbs Etf Etf (MBB)
Ishares Russell 1000 Growth Etf Etf (IWF)
Amazon Stock (AMZN)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)

View all positions for Park Place Capital Corp

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
UBS Group
Goldman Sachs Group
Oracle Investment Management

View all funds holding Eyepoint Pharmaceuticals